The minimal important difference of Saint George’s Respiratory Questionnaire in subjects with chronic pulmonary aspergillosis-Reference-Cited by-同舟云学术

The minimal important difference of Saint George’s Respiratory Questionnaire in subjects with chronic pulmonary aspergillosis

Published:2023-04-29 Issue:5 Volume:61 Page:
ISSN:1369-3786
Container-title:Medical Mycology
language:en
Short-container-title:

Author:

Sehgal Inderpaul Singh¹^ORCID,Dhooria Sahajal¹,Muthu Valliappan¹^ORCID,Prasad Kuruswamy Thurai¹,Aggarwal Ashutosh Nath¹,Chakrabarti Arunaloke²^ORCID,Rudramurthy Shivaprakash M¹³^ORCID,Agarwal Ritesh¹

Affiliation:

1. Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh , India

2. Doodhadhari Burfani Hospital and Research Institute , Haridwar , India

3. Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh , India

Abstract

Abstract The estimates of the minimal important difference (MID) for the Saint George’s Respiratory Questionnaire (SGRQ) score in chronic pulmonary aspergillosis (CPA) remain unknown. We performed a retrospective analysis on treatment-naïve CPA subjects (n = 148) treated with 6-month oral itraconazole therapy and completed SGRQ at baseline and 6 months. The study’s objective was to estimate the MID for SGRQ. We used an anchor-based method to determine the MID and found the MID for SGRQ of 7.3.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine

Link

https://academic.oup.com/mmy/advance-article-pdf/doi/10.1093/mmy/myad048/50249236/myad048.pdf

Reference12 articles.

1. Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India;Sehgal;Lancet Infect Dis,2022

2. Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers;Sehgal;Clin Microbiol Infect,2019

3. Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis;Al-Shair;Clin Infect Dis,2013

4. Validity and reliability of the St. George’s Respiratory Questionnaire in assessing health status in patients with chronic pulmonary aspergillosis;Al-Shair;Chest,2013

5. Utility of St. George's Respiratory Questionnaire in predicting clinical recurrence in chronic pulmonary aspergillosis;Bongomin;Ther Adv Infect Dis,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The minimal important difference of one-minute-sit-to-stand test in subjects with chronic pulmonary aspergillosis;Lung India;2024-08-31